2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Medical Imaging And Therapeutics
Medical imaging plays a crucial role in cancer research by enabling early detection, accurate diagnosis, and targeted treatment. Advanced imaging techniques such as MRI, CT scans, PET scans, and ultrasound allow doctors to visualize tumors and assess their size, location, and characteristics with high precision. This information is vital for determining the most effective treatment approach, whether it be surgery, radiation therapy, chemotherapy, or immunotherapy. Moreover, medical imaging facilitates monitoring of treatment response and disease progression, helping clinicians make informed decisions about adjusting therapies as needed. Additionally, emerging technologies like molecular imaging and theranostics offer promising avenues for personalized cancer treatment by combining imaging and therapeutic agents to deliver targeted therapy directly to cancer cells while minimizing damage to healthy tissue. Through continual advancements in medical imaging and therapeutics, researchers strive to improve outcomes for cancer patients worldwide.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China